secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0001104659-24-122149
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma receives Nasdaq delisting notice for equity-rule non-compliance
----------------------------------------------------------------------------

- Nasdaq Staff notified Company on Nov 20, 2024 of non-compliance with $2.5M stockholders' equity requirement (Listing Rule 5550(b)(1)).
- Company self-reported equity shortfall and requested Nov 14 hearing solely on equity rule; bid-price compliance was regained on Oct 29.
- Awaiting determination from Nasdaq Hearings Panel; delisting remains a risk if plan not accepted.
- Previously disclosed bid-price non-compliance resolved by 10 consecutive closing bids above $1.00/share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465924122149/0001104659-24-122149-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465924122149/tm2429248d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-122149

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer